EMA's New Cost-Based Fee Structure Gets Final Go-Ahead From EU Ministers
Executive Summary
EFPIA has welcomed the adoption of the new regulation, which will take effect from January 2025. However, it cautioned that the EMA and the national agencies needed to have the necessary resources to do their job and that the new fee structure should be supported by revisions to the EU pharmaceutical legislation.